Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography
- 76 Downloads
In previousin vivo studies with mice, rats and monkeys, we have demonstrated that [11C]TMSX ([7-methyl-11C]-(E)-8-(3,4,5-trimethoxystyryl)-1,3,7-trimethylxanthine) is a potential radioligang for mapping adenosine A2A receptors of the brain by positron emission tomography (PET). In the present study, we performed a preclinical study. A suitable preparation method for [11C]TMSX injection was established. The radiation absorbed-dose by [11C]TMSX in humans estimated from the tissue distribution in mice was low enough for clinical use, and the acute toxicity and mutagenicity of TMSX were not found. The striatal uptake of [11C]TMSX in mice was reduced by pretreatment with theophylline at the dose of 10 and 100mg/kg, suggesting that the [11C]TMSX PET should be carefully performed in the patients received with theophylline. We have concluded that [11C]TMSX is suitable for mapping adenosine A2A receptors in the human brain by PET.
Key wordsAdenosine A2A receptor [11C]TMSX central nervous system positron emission tomography
Unable to display preview. Download preview PDF.
- 16.Tissingh G, Booij J, Winogrodzka A, van Royen EA, Wolters EC. IBZM-and CIT-SPECT of the dopaminergic system in parkinsonism.J Neural Transm 1997; 50 (Suppl): 1–7.Google Scholar
- 31.Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: A target compound for PET and boron neutron capture therapy.Appl Radiat Isot 1991; 142: 325–328.Google Scholar